Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Clinical trial NCT06191744 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06191744
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-05
- Primary completion
- 2037-11-01
- Enrollment
- 1095
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.